e.g. mhealth
Search Results (1 to 10 of 22 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 6 JMIR Formative Research
- 4 Journal of Medical Internet Research
- 3 JMIR Medical Informatics
- 3 JMIR Research Protocols
- 1 JMIR AI
- 1 JMIR Aging
- 1 JMIR Cardio
- 1 JMIR Mental Health
- 1 JMIR Perioperative Medicine
- 1 JMIR mHealth and uHealth
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Public Health and Surveillance
- 0 JMIR Serious Games
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
For our outcomes, we examined readmission within 30 days or mortality within 30 days postdischarge. For readmission and mortality within 30 days, there were no missing data. For those who were readmitted to a non-Kaiser hospital, we identified their readmission through claim data. The study was limited to health plan members only, for whom we had full data on mortality.
JMIR Med Inform 2025;13:e69102
Download Citation: END BibTex RIS
Readmission is an unintended outcome that occurs in patients discharged from the hospital. In South Korea, the 30-day readmission rate in tertiary general hospitals in 2020 was approximately 30%, increasing yearly along with readmission cost statistics [1]. According to a Center for Medicare and Medicaid Services report in the United States, readmission rates for patients reach 2 million yearly, with readmissions costing $26 billion [2].
JMIR Med Inform 2025;13:e56671
Download Citation: END BibTex RIS
Across all diagnoses, admission carried a significantly greater adjusted risk than a discharge of 30-day readmission (RD=5.8%, 95% CI 5.0 to 6.5). Individual diagnoses yielded adjusted estimates in the same direction as that of the entire sample, but the magnitude was notably larger in a few cases. For patients with weakness, admission carried a greater adjusted risk than a discharge 30-day readmission (RD=61.6%, 95% CI 57.7 to 65.5).
JMIR Aging 2025;8:e55929
Download Citation: END BibTex RIS
Predictive Modeling of Hypertension-Related Postpartum Readmission: Retrospective Cohort Analysis
All-cause hospital readmission rates are on the rise with risk factors for all-cause postpartum readmission including public insurance, race, presence of comorbid conditions including hypertension and diabetes, and cesarean section [3].
JMIR AI 2024;3:e48588
Download Citation: END BibTex RIS
This includes those who received ICU treatment, high-risk discharges, and patients with thoracic and cardiovascular conditions with high readmission rates. The primary goal is to monitor disease control status, medication adherence, vital sign changes, and self-care ability.
JMIR Form Res 2024;8:e53455
Download Citation: END BibTex RIS
To the best of our knowledge, to date, no study exists that applied ML to only outpatient SHI data to predict all-cause readmission in HF.
The aims of this study were (1) to evaluate the use of outpatient SHI data to predict 1-year all-cause (primary end point) and HF-specific (secondary end point) readmission after an initial admission for HF and (2) to identify and rank relevant predictors for readmission.
JMIR Cardio 2024;8:e54994
Download Citation: END BibTex RIS
Discharge coordination (DC) has been tested for years, especially in North America and Japan, to reduce the rate of readmission within 30 days, also with mixed results [18-20]. In Europe, concerns over readmission rates are less of a financial concern, but the same lack of coordination issue at discharge remains [21]. Diseases and related treatments are becoming increasingly complex, and multimorbidities represent a challenge in coordination.
JMIR Form Res 2024;8:e51728
Download Citation: END BibTex RIS
In terms of treated cases, the readmission rate was 9.07% (1222/13,477). The rates increased to 17.1% (1542/9016) for patients and 18.85% (1975/10,478) for cases when considering a longer time horizon for the readmission (90 days). Readmission rates were generally higher in the intervention group (80/705, 11.3%) at 30 days and 28.8% (161/560 at 90 days) than in the hospital as a whole and the control group.
J Med Internet Res 2024;26:e47133
Download Citation: END BibTex RIS
While this readmission risk underscores that patients receive life-saving care, it also encompasses implications of health care costs, patient’s stress, and the impact of socioeconomic determinants on care outcomes [2]. The risk of readmission due to the worsening of HF symptoms is heightened by inappropriate treatment strategies, infectious complications, or prematurely executed discharges.
JMIR Res Protoc 2024;13:e52744
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section